INFO Among Large Cap ETFs
End-of-day Nov 17, 2026 · 300 Large cap ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.2% | −2.7% | −5.7% | −5.5% | +8.7% | +10.7% | — | — | — | +33.1% |
| Peer average | −1.1% | −2.4% | −3.7% | −5.0% | +8.0% | +10.1% | +61.2% | +49.9% | +222.2% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$88 of every $1,000 in INFO is Apple
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | AAPLApple | Technology | 8.78% | $877.71 | 248K | $87.3M |
| 2 | NVDANvidia | Technology | 6.45% | $644.55 | 411K | $64.1M |
| 3 | MSFTMicrosoft | Technology | 6.27% | $627.12 | 120K | $62.4M |
| 4 | GOOGLAlphabet | Communication Services | 5.07% | $507.41 | 178K | $50.5M |
| 5 | AMZNAmazon | Consumer Cyclical | 3.64% | $364.13 | 141K | $36.2M |
| 6 | METAMETA Platforms | Communication Services | 2.41% | $241.48 | 38K | $24.0M |
| 7 | LLYELI Lilly | Healthcare | 2.37% | $237.00 | 16K | $23.6M |
| 8 | AVGOBroadcom | Technology | 1.98% | $198.15 | 59K | $19.7M |
| 9 | JNJJohnson & Johnson | Healthcare | 1.86% | $186.25 | 66K | $18.5M |
| 10 | ABBVAbbvie | Healthcare | 1.59% | $159.03 | 54K | $15.8M |
| 11 | AMDAdvanced Micro Devices | Technology | 1.45% | $145.29 | 29K | $14.5M |
| 12 | MUMicron Technology | Technology | 1.43% | $142.95 | 20K | $14.2M |
| 13 | PMPhilip Morris International | Consumer Defensive | 1.34% | $134.27 | 68K | $13.4M |
| 14 | TSLATesla | Consumer Cyclical | 1.23% | $122.80 | 32K | $12.2M |
| 15 | MAMastercard | Financial Services | 1.18% | $118.39 | 18K | $11.8M |
of the $839B in 304 Large cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | AAPL | Apple | 8.78% |
| 2 | NVDA | Nvidia | 6.45% |
| 3 | MSFT | Microsoft | 6.27% |
| 4 | GOOGL | Alphabet - | 5.07% |
| 5 | AMZN | Amazon | 3.64% |
| 6 | META | META Platforms - | 2.41% |
| 7 | LLY | ELI Lilly & | 2.37% |
| 8 | AVGO | Broadcom | 1.98% |
| 9 | JNJ | Johnson & Johnson | 1.86% |
| 10 | ABBV | Abbvie | 1.59% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2025 | Dec 24, 2025 | $0.0859 |
| Dec 20, 2024 | Dec 26, 2024 | $0.0333 |